Stay updated on APL-501 with APL-101 in HCC and RCC Clinical Trial
Sign up to get notified when there's something new on the APL-501 with APL-101 in HCC and RCC Clinical Trial page.

Latest updates to the APL-501 with APL-101 in HCC and RCC Clinical Trial page
- Check6 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check13 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference1%
- Check20 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.2%
- Check27 days agoNo Change Detected
- Check42 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check56 days agoChange DetectedThe web page has been updated to reflect a new version of the study, including the addition of the study's name 'Hepatocellular Carcinoma' and the collaborators involved, Apollomics Inc. and Novotech. The detailed study design and investigational plan have been removed, indicating a shift in focus or a simplification of the content.SummaryDifference35%
- Check63 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
Stay in the know with updates to APL-501 with APL-101 in HCC and RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the APL-501 with APL-101 in HCC and RCC Clinical Trial page.